Results 241 to 250 of about 891,116 (360)
Tobacco Control and Smoking Cessation-Related Content in Oncology Meetings: A Systematic Scoping Review. [PDF]
Choi S +13 more
europepmc +1 more source
Advancing cardio‐obstetric care through digital health technologies: A narrative review
Telehealth has enhanced prenatal and post‐partum care by improving access, continuity, and equity, particularly for high‐risk and underserved populations, without compromising maternal or fetal outcomes. Wearable and digital health technologies (e.g., electrocardiogram sensors, remote BP monitoring, mobile interventions) show strong potential to ...
Toluwalase Awoyemi +11 more
wiley +1 more source
Recommendations to advance equity in tobacco control. [PDF]
Mills SD +4 more
europepmc +1 more source
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy
Safety and prognostic value of left ventricular endomyocardial biopsy in dilated cardiomyopathy. CVF, left ventricular collagen volume fraction; DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; LV, left ventricular. Aims The need to perform endomyocardial biopsy (EMB) in patients with non‐ischaemic dilated cardiomyopathies (DCM) is debated ...
Elham Kayvanpour +15 more
wiley +1 more source
Tobacco control in complex emergencies: Policy case study of Ukraine. [PDF]
Skipalskyi A +4 more
europepmc +1 more source
Self‐Discontinuity as a Barrier to Identity and Behaviour Change: Evidence From Smoking Cessation
ABSTRACT Extensive research has shown that resistance to behaviour change is often driven by the management of self‐related threats, traditionally conceptualized as threats to self‐esteem. The present research offers a novel perspective by examining behaviour change as a threat to self‐continuity (i.e., the perceived stability of one's self‐image over ...
Jérôme Blondé +1 more
wiley +1 more source
Projecting the impact of strengthened tobacco control policy on disparities in US states with persistently high smoking rates. [PDF]
Donovan EM +4 more
europepmc +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source

